Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B.

International journal of molecular sciences·2026
Same author

How and Why Does Knowledge-Based Biased Docking Improve Molecular Docking Performance?

ChemMedChem·2026
Same author

Moulting and development in a freshwater prawn from the Cretaceous of Morocco.

PeerJ·2026
Same author

Best Practices in Mixed-Solvent Molecular Dynamics and Solvent-Site-Biased Docking.

Journal of chemical information and modeling·2026
Same author

Beyond Tanimoto: a learned bioactivity similarity index enhances ligand discovery.

Frontiers in bioinformatics·2025
Same author

Water Networks as Hydrophobic Recognition Motifs in Proteins.

Angewandte Chemie (International ed. in English)·2025

Related Experiment Video

Updated: Apr 30, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K

TuberQ: a Mycobacterium tuberculosis protein druggability database.

Leandro Radusky1, Lucas A Defelipe, Esteban Lanzarotti

  • 1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón II, Buenos Aires C1428EHA, Argentina, INQUIMAE/UBA-CONICET, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón II, Buenos Aires C1428EHA, Argentina, Department of Physical Chemistry, Faculty of Pharmacy and Institute of Biomedicine (IBUB), University of Barcelona, Campus de l'Alimentació Torribera, Avgda. Prat de la Riba 171, Santa Coloma de Gramenet 08921, Spain, Department of Physical Chemistry, Faculty of Pharmacy and Institute of Biomedicine (IBUB), University of Barcelona, Avgda. Diagonal 643, Barcelona 08028, Spain and Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, Barcelona 08010, Spain.

Database : the Journal of Biological Databases and Curation
|May 13, 2014
PubMed
Summary

Tuberculosis drug discovery is advanced by the TuberQ database, which analyzes Mycobacterium tuberculosis proteins for potential drug targets. This resource aids researchers in identifying new anti-TB therapies by assessing protein druggability and binding pockets.

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K
Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

12.0K

Related Experiment Videos

Last Updated: Apr 30, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K
Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

12.0K

Area of Science:

  • Biochemistry
  • Drug Discovery
  • Bioinformatics

Background:

  • Tuberculosis (TB) remains a major global health challenge, with millions of new cases and deaths annually.
  • Existing TB treatments face limitations including severe side effects, drug resistance, drug-drug interactions (especially with HIV treatments), and ineffectiveness against dormant bacteria.
  • There is an urgent need for novel anti-TB drugs and effective drug targets.

Purpose of the Study:

  • To introduce TuberQ, a novel database resource for researchers in TB drug development.
  • To provide a comprehensive druggability analysis of Mycobacterium tuberculosis (Mtb) proteins.
  • To facilitate the selection of potential drug targets for screening and structure-based drug design.

Main Methods:

  • Structural analysis of all available unique Mtb protein structures and homology models.
  • Assessment of inhibitor binding pocket characteristics.
  • Integration of functional, biological, gene essentiality, and expression data.

Main Results:

  • The TuberQ database offers an interactive platform for visualizing Mtb protein structures, pockets, and associated data.
  • It systematically analyzes protein druggability, aiding in the identification of promising drug targets.
  • The database integrates diverse data types, including gene essentiality and stress-condition expression profiles.

Conclusions:

  • TuberQ serves as a powerful tool for TB researchers, enhancing drug discovery efforts.
  • The database facilitates the identification of novel drug targets and potential therapeutic strategies against TB.
  • By providing integrated structural and functional data, TuberQ supports the development of new anti-TB treatments.